biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by IMBROKE2on Dec 06, 2012 2:34pm

196 Views

Post# 20694088

RE: RE: RE: RE: I would post somthing but...

I don't have to have a logical argument cuz the market sifts through the bs and facts and makes a judgement and I'm seeing that Mr. Market knows more than you and all of us peons. Unless you see something else on the stock price (which you should get treated for) the stock is going down and people are selling.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!